Literature DB >> 11121396

Isoprenylcysteine carboxyl methyltransferase deficiency in mice.

M O Bergo1, G K Leung, P Ambroziak, J C Otto, P J Casey, A Q Gomes, M C Seabra, S G Young.   

Abstract

After isoprenylation, Ras and other CAAX proteins undergo endoproteolytic processing by Rce1 and methylation of the isoprenylcysteine by Icmt (isoprenylcysteine carboxyl methyltransferase). We reported previously that Rce1-deficient mice died during late gestation or soon after birth. We hypothesized that Icmt deficiency might cause a milder phenotype, in part because of reports suggesting the existence of more than one activity for methylating isoprenylated proteins. To address this hypothesis and also to address the issue of other methyltransferase activities, we generated Icmt-deficient mice. Contrary to our expectation, Icmt deficiency caused a more severe phenotype than Rce1 deficiency, with virtually all of the knockout embryos (Icmt-/-) dying by mid-gestation. An analysis of chimeric mice produced from Icmt-/- embryonic stem cells showed that the Icmt-/- cells retained the capacity to contribute to some tissues (e.g. skeletal muscle) but not to others (e.g. brain). Lysates from Icmt-/- embryos lacked the ability to methylate either recombinant K-Ras or small molecule substrates (e.g. N-acetyl-S-geranylgeranyl-l-cysteine). In addition, Icmt-/- cells lacked the ability to methylate Rab proteins. Thus, Icmt appears to be the only enzyme participating in the carboxyl methylation of isoprenylated proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121396     DOI: 10.1074/jbc.C000831200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Amide-modified prenylcysteine based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular characterization.

Authors:  Jaimeen D Majmudar; Heather B Hodges-Loaiza; Kalub Hahne; James L Donelson; Jiao Song; Liza Shrestha; Marietta L Harrison; Christine A Hrycyna; Richard A Gibbs
Journal:  Bioorg Med Chem       Date:  2011-11-06       Impact factor: 3.641

2.  Membrane trafficking of heterotrimeric G proteins via the endoplasmic reticulum and Golgi.

Authors:  David Michaelson; Ian Ahearn; Martin Bergo; Stephen Young; Mark Philips
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

3.  Fighting cancer by disrupting C-terminal methylation of signaling proteins.

Authors:  Steven Clarke; Fuyuhiko Tamanoi
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 4.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

Review 5.  Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Authors:  Adrienne D Cox; Channing J Der; Mark R Philips
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

6.  Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases.

Authors:  David Michaelson; Wasif Ali; Vi K Chiu; Martin Bergo; Joseph Silletti; Latasha Wright; Stephen G Young; Mark Philips
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

7.  Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect.

Authors:  Martin O Bergo; Bryant Gavino; Jed Ross; Walter K Schmidt; Christine Hong; Lonnie V Kendall; Andreas Mohr; Margarita Meta; Harry Genant; Yebin Jiang; Erik R Wisner; Nicholas Van Bruggen; Richard A D Carano; Susan Michaelis; Stephen M Griffey; Stephen G Young
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

8.  Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression.

Authors:  Helen Court; Marc Amoyel; Michael Hackman; Kyoung Eun Lee; Ruliang Xu; George Miller; Dafna Bar-Sagi; Erika A Bach; Martin O Bergö; Mark R Philips
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Farnesylation of retinal transducin underlies its translocation during light adaptation.

Authors:  Hidetoshi Kassai; Atsu Aiba; Kazuki Nakao; Kenji Nakamura; Motoya Katsuki; Wei-Hong Xiong; King-Wai Yau; Hiroo Imai; Yoshinori Shichida; Yoshinori Satomi; Toshifumi Takao; Toshiyuki Okano; Yoshitaka Fukada
Journal:  Neuron       Date:  2005-08-18       Impact factor: 17.173

10.  The role of the hypervariable C-terminal domain in Rab GTPases membrane targeting.

Authors:  Fu Li; Long Yi; Lei Zhao; Aymelt Itzen; Roger S Goody; Yao-Wen Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.